An in vitro model for essential fatty acid deficiency: HepG2 cells permanently maintained in lipid-free medium

E. E. Furth, H. Sprecher, E. A. Fisher, H. D. Fleishman, Michael Laposata

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

A stable essential fatty acid-deficient cell type, known as HepG2-EFD, was derived from the lipoprotein-producing human hepatoma cell line HepG2. These cells are particularly useful for quantitative studies involving essential fatty acids (n-6 and n-3 fatty acids) in secreted lipoproteins. Radiolabeled essential fatty acids can be delivered to these cells without altering the specific activity of the fatty acids, since the deficient cells contain no endogenous essential fatty acids. Using these cells, radioactivity data (dpm) from metabolic studies can be converted directly to mass, and masses as low as a few pmoles can be accurately measured. HepG2-EFD cell cultures were established by growing HepG2 cells in medium containing delipidated serum. After 10 days of growth in delipidated medium, HepG2 cells were completely depleted of all essential fatty acids. Compensatory increases in nonessential fatty acids (n-9 and n-7 fatty acids) including 20:3n-9 (the Mead acid), which is the hallmark fatty acid of essential fatty acid deficiency, were also observed in HepG2-EFD cells. Despite the lack of exogenous fatty acids in the medium and the lack of essential fatty acids in the cells, export of very low density lipoprotein (VLDL)-associated apolipoprotein B by HepG2-EFD was the same as observed for parent HepG2 cells. However, the activity of beta-oxidation of fatty acids in HepG2-EFD cells was much lower than in the parent cell line. The doubling time was the same for both cell types, but depletion of essential fatty acids resulted in a phenotypic change, whereby HepG2 cells proliferated in large clusters of cells, but HepG2-EFD cells proliferated as homogeneously dispersed cell monolayers. Thus, cultures of HepG2-EFD cells provide an in vitro model for essential fatty acid deficiency, and the model has fatty acid changes consistent with those found in vivo in essential fatty acid deficiency.

Original languageEnglish (US)
Pages (from-to)1719-1726
Number of pages8
JournalJournal of Lipid Research
Volume33
Issue number11
StatePublished - 1992
Externally publishedYes

Fingerprint

Essential Fatty Acids
Hep G2 Cells
Lipids
Fatty Acids
Cells
Lipoproteins
In Vitro Techniques
Cell Line
VLDL Lipoproteins
Radioactivity
Omega-3 Fatty Acids
Apolipoproteins B
Fatty acids
Cell culture
Hepatocellular Carcinoma
Monolayers
Cell Culture Techniques
Oxidation

Keywords

  • arachidonate
  • essential fatty acids
  • Mead acid

ASJC Scopus subject areas

  • Endocrinology

Cite this

An in vitro model for essential fatty acid deficiency : HepG2 cells permanently maintained in lipid-free medium. / Furth, E. E.; Sprecher, H.; Fisher, E. A.; Fleishman, H. D.; Laposata, Michael.

In: Journal of Lipid Research, Vol. 33, No. 11, 1992, p. 1719-1726.

Research output: Contribution to journalArticle

Furth, E. E. ; Sprecher, H. ; Fisher, E. A. ; Fleishman, H. D. ; Laposata, Michael. / An in vitro model for essential fatty acid deficiency : HepG2 cells permanently maintained in lipid-free medium. In: Journal of Lipid Research. 1992 ; Vol. 33, No. 11. pp. 1719-1726.
@article{a6bceb26bb8b4b23811077e84e203882,
title = "An in vitro model for essential fatty acid deficiency: HepG2 cells permanently maintained in lipid-free medium",
abstract = "A stable essential fatty acid-deficient cell type, known as HepG2-EFD, was derived from the lipoprotein-producing human hepatoma cell line HepG2. These cells are particularly useful for quantitative studies involving essential fatty acids (n-6 and n-3 fatty acids) in secreted lipoproteins. Radiolabeled essential fatty acids can be delivered to these cells without altering the specific activity of the fatty acids, since the deficient cells contain no endogenous essential fatty acids. Using these cells, radioactivity data (dpm) from metabolic studies can be converted directly to mass, and masses as low as a few pmoles can be accurately measured. HepG2-EFD cell cultures were established by growing HepG2 cells in medium containing delipidated serum. After 10 days of growth in delipidated medium, HepG2 cells were completely depleted of all essential fatty acids. Compensatory increases in nonessential fatty acids (n-9 and n-7 fatty acids) including 20:3n-9 (the Mead acid), which is the hallmark fatty acid of essential fatty acid deficiency, were also observed in HepG2-EFD cells. Despite the lack of exogenous fatty acids in the medium and the lack of essential fatty acids in the cells, export of very low density lipoprotein (VLDL)-associated apolipoprotein B by HepG2-EFD was the same as observed for parent HepG2 cells. However, the activity of beta-oxidation of fatty acids in HepG2-EFD cells was much lower than in the parent cell line. The doubling time was the same for both cell types, but depletion of essential fatty acids resulted in a phenotypic change, whereby HepG2 cells proliferated in large clusters of cells, but HepG2-EFD cells proliferated as homogeneously dispersed cell monolayers. Thus, cultures of HepG2-EFD cells provide an in vitro model for essential fatty acid deficiency, and the model has fatty acid changes consistent with those found in vivo in essential fatty acid deficiency.",
keywords = "arachidonate, essential fatty acids, Mead acid",
author = "Furth, {E. E.} and H. Sprecher and Fisher, {E. A.} and Fleishman, {H. D.} and Michael Laposata",
year = "1992",
language = "English (US)",
volume = "33",
pages = "1719--1726",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "11",

}

TY - JOUR

T1 - An in vitro model for essential fatty acid deficiency

T2 - HepG2 cells permanently maintained in lipid-free medium

AU - Furth, E. E.

AU - Sprecher, H.

AU - Fisher, E. A.

AU - Fleishman, H. D.

AU - Laposata, Michael

PY - 1992

Y1 - 1992

N2 - A stable essential fatty acid-deficient cell type, known as HepG2-EFD, was derived from the lipoprotein-producing human hepatoma cell line HepG2. These cells are particularly useful for quantitative studies involving essential fatty acids (n-6 and n-3 fatty acids) in secreted lipoproteins. Radiolabeled essential fatty acids can be delivered to these cells without altering the specific activity of the fatty acids, since the deficient cells contain no endogenous essential fatty acids. Using these cells, radioactivity data (dpm) from metabolic studies can be converted directly to mass, and masses as low as a few pmoles can be accurately measured. HepG2-EFD cell cultures were established by growing HepG2 cells in medium containing delipidated serum. After 10 days of growth in delipidated medium, HepG2 cells were completely depleted of all essential fatty acids. Compensatory increases in nonessential fatty acids (n-9 and n-7 fatty acids) including 20:3n-9 (the Mead acid), which is the hallmark fatty acid of essential fatty acid deficiency, were also observed in HepG2-EFD cells. Despite the lack of exogenous fatty acids in the medium and the lack of essential fatty acids in the cells, export of very low density lipoprotein (VLDL)-associated apolipoprotein B by HepG2-EFD was the same as observed for parent HepG2 cells. However, the activity of beta-oxidation of fatty acids in HepG2-EFD cells was much lower than in the parent cell line. The doubling time was the same for both cell types, but depletion of essential fatty acids resulted in a phenotypic change, whereby HepG2 cells proliferated in large clusters of cells, but HepG2-EFD cells proliferated as homogeneously dispersed cell monolayers. Thus, cultures of HepG2-EFD cells provide an in vitro model for essential fatty acid deficiency, and the model has fatty acid changes consistent with those found in vivo in essential fatty acid deficiency.

AB - A stable essential fatty acid-deficient cell type, known as HepG2-EFD, was derived from the lipoprotein-producing human hepatoma cell line HepG2. These cells are particularly useful for quantitative studies involving essential fatty acids (n-6 and n-3 fatty acids) in secreted lipoproteins. Radiolabeled essential fatty acids can be delivered to these cells without altering the specific activity of the fatty acids, since the deficient cells contain no endogenous essential fatty acids. Using these cells, radioactivity data (dpm) from metabolic studies can be converted directly to mass, and masses as low as a few pmoles can be accurately measured. HepG2-EFD cell cultures were established by growing HepG2 cells in medium containing delipidated serum. After 10 days of growth in delipidated medium, HepG2 cells were completely depleted of all essential fatty acids. Compensatory increases in nonessential fatty acids (n-9 and n-7 fatty acids) including 20:3n-9 (the Mead acid), which is the hallmark fatty acid of essential fatty acid deficiency, were also observed in HepG2-EFD cells. Despite the lack of exogenous fatty acids in the medium and the lack of essential fatty acids in the cells, export of very low density lipoprotein (VLDL)-associated apolipoprotein B by HepG2-EFD was the same as observed for parent HepG2 cells. However, the activity of beta-oxidation of fatty acids in HepG2-EFD cells was much lower than in the parent cell line. The doubling time was the same for both cell types, but depletion of essential fatty acids resulted in a phenotypic change, whereby HepG2 cells proliferated in large clusters of cells, but HepG2-EFD cells proliferated as homogeneously dispersed cell monolayers. Thus, cultures of HepG2-EFD cells provide an in vitro model for essential fatty acid deficiency, and the model has fatty acid changes consistent with those found in vivo in essential fatty acid deficiency.

KW - arachidonate

KW - essential fatty acids

KW - Mead acid

UR - http://www.scopus.com/inward/record.url?scp=0026442356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026442356&partnerID=8YFLogxK

M3 - Article

C2 - 1464755

AN - SCOPUS:0026442356

VL - 33

SP - 1719

EP - 1726

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 11

ER -